Hair, Hormones, and the Symptoms Nobody Warned You About

Episode Script

Thanks Toni. We've got a good one today.

Hair thinning, a reframe of a hormone you've probably had tested, and a list of symptoms that are genuinely common in menopause but that most women have no idea are connected to it. Three things that, in different ways, all point at the same gap: how much goes unrecognized, and how often women get told it's stress or aging when it's actually something with a name and a mechanism.

Let's start with hair.

Dr. Mary Claire Haver did a solo episode of her podcast unPAUSED recently — she's calling it a masterclass on midlife hair loss, and the framing I want to push on is this: hair thinning is a medical condition with identifiable causes, not a vanity complaint. That distinction matters, because "vanity complaint" is exactly how a lot of women have had this received when they bring it up with a doctor.

The biology goes like this. Hair grows in cycles — a growth phase, a resting phase, then the hair sheds and the follicle starts over. Estrogen, when it's at normal levels, keeps hair in the growth phase longer. As estrogen drops in perimenopause and menopause, that growth phase shortens. At the same time, androgens — male-type hormones, particularly one called DHT — become relatively more dominant. DHT binds to receptors in the hair follicle and, over time, shrinks it. A smaller follicle produces a thinner strand. Eventually it may stop producing hair at all. This is the same process that drives male-pattern baldness, but in women it tends to show up as overall thinning — especially at the crown and part line — rather than a receding hairline.

That mechanism is real and well-established. What Haver is doing, and what I think is genuinely useful, is insisting that women and their doctors treat it as such. Not "you're stressed" or "it happens as you age." It's a hormonal process you can investigate. There are blood tests that matter here — thyroid function, iron and ferritin levels, androgens — and there are interventions with actual evidence behind them. Minoxidil has the most robust data. Spironolactone is used off-label for the androgen component. Some women respond to HRT. None of this is a guaranteed fix, and results are slow — we're talking months, not weeks — but there is a path to actually assessing and addressing this, and that's different from being told to manage your stress.

The piece that I find worth saying plainly: if you've brought up hair thinning to a doctor and been brushed off, that brush-off is not a diagnosis. It may just be a knowledge gap. Pushing for a full thyroid panel, a ferritin level, and a conversation about androgens is not being difficult. It's asking for a basic workup.

Now — that FSH paper.

FSH stands for follicle-stimulating hormone. If you've ever had a lab test to figure out whether you're in perimenopause or menopause, FSH was probably on it. When it's high — roughly above 40 on the standard scale — that's generally taken as confirmation that your ovaries are winding down. That's been the main story about FSH for decades. It's a signal. It tells you where you are in the transition.

A paper published in August 2026 on PubMed, by researcher Deanna Minich, is arguing that framing is too small. The title itself is a question: Is FSH misnamed? The argument is that FSH isn't just a reproductive hormone that happens to spike during menopause. It may be an active player in what happens to your bones, your brain, and your metabolism during that transition.

Here's what the research points to. FSH receptors — the places in your body where FSH can actually dock and do something — have been found not just in the ovaries, but in bone cells, in fat tissue, in the hypothalamus, which is a part of the brain that regulates appetite, temperature, and sleep. When FSH is high, bone breakdown may increase. There are signals connecting high FSH to changes in how fat is stored — particularly the shift toward belly fat that a lot of women notice in this stage. There may be effects on brain function too, though that part of the research is earlier and less settled.

The paper's core claim is that we've been treating FSH as a messenger — something that tells us about what the ovaries are doing — when it may actually be an actor. It might be actively driving some of the changes in bone density, body composition, and cognition that we've attributed entirely to low estrogen.

I want to be honest about the evidence here, because this is a review paper, not a clinical trial. It's a researcher synthesizing existing findings and making an argument for a new lens. That's a legitimate and valuable kind of science, but it's not the same as a randomized controlled trial showing that blocking FSH reverses bone loss. The kind of evidence your doctor would look at on a tool like OpenEvidence is going to be more conservative on this than the paper's framing. So I'm not suggesting anyone run to their doctor demanding a new treatment based on this. What I am saying is: if FSH turns out to be doing more than we thought, it changes what we'd want to measure and potentially what we'd want to target. And the fact that FSH receptors exist in bone and brain tissue isn't speculative — that's established. The question of what FSH is actively doing there, that's what the research is still working out.

What this paper does do well is reframe a number. A lot of women see a high FSH on a lab report and understand it to mean "yep, menopause." This research suggests it might be worth thinking of that number differently — not just as a marker of where you are, but as a hormone that's actively elevated and potentially doing things in your body in that elevated state. That's a different way of thinking about it, and if the research continues in this direction, it could genuinely change how menopause is managed.

The third thing today is about symptoms that catch women completely off-guard.

Dr. Lauren Streicher had Dr. Makeba Williams on her podcast Inside Information to talk about what they're calling "esoteric symptoms" of menopause. The definition they use is specific and I think it's useful: an esoteric symptom isn't a rare one. It's a common symptom that's rarely discussed and rarely connected to menopause — so women experience it and have no frame for it.

The list Dr. Williams goes through includes some things that I think will make a lot of listeners go "oh, that's what that is."

Joint pain and stiffness, especially in the morning. Estrogen has an anti-inflammatory effect, and when it drops, inflammation can increase in the joints. This is well-documented. Women in perimenopause frequently show up to rheumatologists before they ever connect the joint pain to hormonal changes.

Itchy skin — not from a rash, not from a product, just an internal itch that's hard to locate. Estrogen helps maintain the skin's moisture and nerve regulation. When it drops, some women get a sensation called formication, which is the feeling of something crawling under the skin. That is a real, named symptom of estrogen decline, and it is wild that more women don't know about it.

Electric shock sensations. Brief, like a zap that comes out of nowhere, sometimes right before a hot flash. This is more common than most people realize. The mechanism isn't completely worked out, but it's thought to relate to changes in how nerve signals fire as estrogen fluctuates.

Tinnitus — ringing or buzzing in the ears. There are estrogen receptors in the auditory system. Some women notice tinnitus starting or worsening in perimenopause, and the connection to hormonal changes is something researchers are actively investigating.

Burning mouth syndrome. A persistent burning or tingling sensation in the mouth — on the tongue, the lips, the inside of the cheeks — with no obvious dental cause. It disproportionately affects women in the menopause transition. Most of the time it gets routed to dentists or gastroenterologists, and frequently nothing is found, because the cause is hormonal.

Dr. Williams makes a point that I think is the most important one in this episode: these symptoms are common. They're not rare edge cases. But because nobody connects them to menopause — not patients, not always clinicians — women end up spending time and money chasing individual diagnoses for symptoms that share an underlying cause. The joint pain gets investigated separately from the sleep disruption, which gets investigated separately from the mood changes, which gets investigated separately from the burning mouth. And sometimes all of those things are the same story.

That's not an argument against investigating individual symptoms — some of them genuinely do need their own workup. It's an argument for having menopause in the differential from the start, especially for women in their 40s and early 50s. When a woman in that age range walks in with new joint pain, or new tinnitus, or a skin sensation she can't explain, the first question worth asking is what's happening hormonally. Not because menopause is always the answer, but because ruling it out should be fast and it often isn't done at all.

---

Sources curated automatically by the Hot Flasher pipeline.